...
首页> 外文期刊>Cancer letters >Recombinant bispecific single chain antibody fragments induce Fc gamma-receptor-mediated elimination of CD30+ lymphoma cells.
【24h】

Recombinant bispecific single chain antibody fragments induce Fc gamma-receptor-mediated elimination of CD30+ lymphoma cells.

机译:重组双特异性单链抗体片段可诱导Fcγ受体介导的CD30 +淋巴瘤细胞消除。

获取原文
获取原文并翻译 | 示例
           

摘要

Bispecific molecules (BSMs) facilitate the targeting of immune effector cells to tumor cells. Here we describe the construction and characterization of a recombinant BSM comprising two single chain fragments: H22(scFv), targeting the Fc gamma-receptor (CD64) on monocytes, and Ki4(scFv), targeting CD30 on Hodgkin lymphoma cells. A homologous, chemically-linked BSM has been described previously, but is heterogeneous and difficult to prepare. The recombinant version is easier to prepare and homogeneous, yet retains the antigen specificities and efficiently triggers CD64-related effector functions. The elimination of lymphoma cells was preferentially achieved by phagocytosis, not through the ADCC pathway additionally activated by the chemically-linked molecule.
机译:双特异性分子(BSM)有助于将免疫效应细胞靶向肿瘤细胞。在这里,我们描述了包含两个单链片段的重组BSM的构建和表征:靶向单核细胞上的Fcγ受体(CD64)的H22(scFv)和靶向霍奇金淋巴瘤细胞上的CD30的Ki4(scFv)。先前已经描述了同源的,化学连接的BSM,但是其是异质的并且难以制备。重组形式更易于制备和均质,但保留了抗原特异性并有效触发了CD64相关的效应子功能。淋巴瘤细胞的消除优先通过吞噬作用实现,而不是通过化学连接分子额外激活的ADCC途径实现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号